Caplin Point shares drop 4.9% despite 18% Q2 revenue growth
The pharmaceutical firm posted 18% revenue growth and higher margins, yet the stock dropped nearly 5% in the latest session.
The pharmaceutical firm posted 18% revenue growth and higher margins, yet the stock dropped nearly 5% in the latest session. Published 2026-11-12 by Falling Shares.
| By Falling Shares Intelligence, edited by Wung Thomas, Editor-in-Chief
Written by Falling Shares Intelligence, our automated newsroom, from the public sources listed below and live market data. Every figure is checked against that material before publication, but the story has not been reviewed by a human editor. Check the linked sources before relying on it, and report errors to info@fallingshares.com.
Caplin Point Laboratories shares fell 4.92% to 2,396.85 INR on Thursday after the company reported second-quarter results showing strong top-line growth. The decline occurred despite an 18% rise in revenue and a 15% increase in net profit for the period.
Results defy positive metrics
Caplin Point Laboratories reported an 18% rise in Q2 revenue and 15% growth in net profit, according to CNBC TV18. The company also noted that its EBITDA margin improved during the quarter. Despite these positive financial indicators, the shares slipped 4.92% to close at 2,396.85 INR.
The stock lost 4.3% on company-specific factors, while the broader market and sector remained largely flat. The BSE SENSEX was unchanged, and the NIFTY Pharma index fell 0.6% in the same session. None of the reports reviewed by Falling Shares gave a reason for the fall beyond the results release.
High volatility persists
Falling Shares rates the stock Unstable, with annualised volatility of 40.5% compared to 14.0% for the benchmark. The stock has seen nine sessions with moves of 5% or more in the past six months. Over the last month, down days carry 1.6 times the volume of up days, indicating heavy distribution.
In the latest session, the stock traded just 23,266 shares. The 52-week high stands at 2,990.6 INR, with the low at 1,502.45 INR. The market capitalisation is 182.19 billion INR. The stock is currently 16.2% below its 52-week high.